Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 2 call positions ($7.6m notional), 4 put positions ($116.2m notional) – listed below, not included above.
Holdings, Q2 2020
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| HORIZON THERAPEUTICS PUB L HZNP | $53.1m8.76% | New |
| TG THERAPEUTICS INC TGTX | $48.7m8.05% | Added +40.1k |
| AMARIN CORP PLC SPONS ADR NEW | $33.1m5.47% | Added +1.3m |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $32.8m5.41% | Added +341.9k |
| ASCENDIS PHARMA A/S SPONSORED ADR | $32.6m5.38% | Reduced -55.1k |
| ASTRAZENECA PLC SPONSORED ADR | $29.7m4.91% | Added +209.6k |
| UNITED THERAPEUTICS CORP DEL UTHR | $28.2m4.65% | New |
| ZOGENIX INC ZGNX | $27.2m4.49% | Reduced -1.0m |
| HESKA CORP HSKA | $26.1m4.31% | Added +259.5k |
| DECIPHERA PHARMACEUTICALS IN DCPH | $25.0m4.13% | Added +4.6k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $23.1m3.82% | Reduced -2.7m |
| DANAHER CORPORATION DHR | $19.1m3.15% | Reduced -126.1k |
| FATE THERAPEUTICS INC FATE | $18.2m3.01% | Added +225.8k |
| ENSIGN GROUP INC ENSG | $17.9m2.96% | Added +70.3k |
| MYOVANT SCIENCES LTD MYOV | $15.7m2.59% | New |
| APELLIS PHARMACEUTICALS INC APLS | $13.7m2.27% | Reduced -478.5k |
| MODEL N INC MODN | $11.8m1.96% | Reduced -33.5k |
| SAREPTA THERAPEUTICS INC SRPT | $11.5m1.90% | New |
| GLAXOSMITHKLINE PLC SPONSORED ADR | $9.3m1.53% | Reduced -283.3k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $9.3m1.53% | New |
| AURINIA PHARMACEUTICALS INC AUPH | $8.9m1.47% | New |
| LIQUIDIA CORPORATION LQDA | $7.2m1.20% | Added +615.1k |
| TARO PHARMACEUTICAL INDS LTD TARO | $7.0m1.15% | Added +28.7k |
| PACIRA BIOSCIENCES INC PCRX | $7.0m1.15% | New |
| MYOKARDIA INC MYOK | $6.8m1.13% | Added +42.8k |
| OXFORD IMMUNOTEC GLOBAL PLC OXFD | $4.6m0.75% | Added +177.9k |
| AFFIMED N V COM | $4.4m0.72% | Added +382.2k |
| AMNEAL PHARMACEUTICALS INC AMRX | $4.2m0.70% | New |
| AUTOLUS THERAPEUTICS PLC AUTL | $4.1m0.68% | Added +48.3k |
| MOMENTA PHARMACEUTICALS INC MNTA | $4.1m0.68% | Reduced -22.2k |
| QIAGEN NV SHS NEW | $3.5m0.58% | New |
| CYTOKINETICS INC CYTK | $3.3m0.55% | Reduced -40.0k |
| DICERNA PHARMACEUTICALS INC DRNA | $3.3m0.54% | Added +69.1k |
| RADIUS HEALTH INC RDUS | $3.0m0.50% | Reduced -81.0k |
| HCA HEALTHCARE INC HCA | $3.0m0.49% | Reduced -70.6k |
| VAPOTHERM INC COM | $2.9m0.49% | New |
| DEXCOM INC DXCM | $2.7m0.45% | Reduced -12.9k |
| BIODELIVERY SCIENCES INTL IN BDSI | $2.5m0.42% | Added +460.8k |
| SANOFI SNY | $2.5m0.42% | Reduced -139.8k |
| CHEMOCENTRYX INC CCXI | $2.4m0.39% | Reduced -539.2k |
| CONCERT PHARMACEUTICALS INC CNCE | $2.3m0.38% | New |
| PENNANT GROUP INC PNTG | $2.3m0.38% | Reduced -179.6k |
| OTONOMY INC OTIC | $2.2m0.36% | Added +39.4k |
| KINIKSA PHARMACEUTICALS LTD COM CL A | $2.1m0.34% | New |
| ALBIREO PHARMA INC BIOD | $2.1m0.34% | Unchanged |
| STANDARD BIOTOOLS INC LAB | $1.9m0.31% | New |
| SCPHARMACEUTICALS INC SCPH | $1.8m0.30% | Added +115.0k |
| PROTHENA CORP PLC PRTA | $1.6m0.26% | New |
| COMMUNITY HEALTH SYS INC NEW CYH | $1.5m0.24% | Reduced -88.1k |
| CYCLERION THERAPEUTICS INC COM | $1.5m0.24% | Reduced -89.5k |
| ZYMEWORKS INC ZYME | $1.4m0.24% | New |
| SESEN BIO INC COM | $1.4m0.24% | Added +700.0k |
| PROTARA THERAPEUTICS INC TARA | $1.4m0.22% | New |
| XOMA ROYALTY CORPORATION XOMA | $1.3m0.21% | New |
| SOLID BIOSCIENCES INC COM | $1.2m0.20% | New |
| KALVISTA PHARMACEUTICALS INC KALV | $1.1m0.18% | New |
| UNIQURE NV QURE | $1.0m0.17% | New |
| DYNAVAX TECHNOLOGIES CORP DVAX | $867.5k0.14% | New |
| TELIGENT INC NEW COM NEW | $859.1k0.14% | New |
| BURNING ROCK BIOTECH LTD SPONSORED ADS | $810.3k0.13% | New |
| OSMOTICA PHARMACEUTICALS PLC RVLPQ | $531.9k0.09% | New |
| EIGER BIOPHARMACEUTICALS INC CLDN | $470.5k0.08% | Reduced -20.7k |
| IMMUNOVANT INC IMVT | $298.7k0.05% | Reduced -64.6k |
Sold out since Q1 2020
| Security | Value then |
|---|---|
| KADMON HLDGS INC KDMN | $4.1m975.4k shares |
| ACCELERON PHARMA INC XLRN | $3.8m42.3k shares |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $2.7m90.0k shares |
| GENMARK DIAGNOSTICS INC GNMK | $2.2m524.3k shares |
| ENVISTA HOLDINGS CORPORATION NVST | $1.6m109.2k shares |
| AGILE THERAPEUTICS INC AGRX | $1.3m711.8k shares |
| TELIGENT INC NEW | $1.1m3.9m shares |
| XENON PHARMACEUTICALS INC XENE | $811.8k71.6k shares |
| ARTARA THERAPEUTICS INC PRTO | $747.0k32.5k shares |
| INFLARX NV IFRX | $746.8k195.5k shares |
| AQUESTIVE THERAPEUTICS INC AQST | $657.0k300.0k shares |
| IGM BIOSCIENCES INC IGMS | $548.6k9.8k shares |
| MACROGENICS INC MGNX | $535.4k92.0k shares |
| PUMA BIOTECHNOLOGY INC PBYI | $491.6k58.3k shares |
| EHEALTH INC EHTH | $444.0k3.2k shares |
| PFENEX INC PFNX | $408.3k46.3k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $104.8m340.0k shares | Added |
| SELECT SECTOR SPDR TR XLV · Put | $8.0m80.0k shares | New |
| AMARIN CORP PLC Call | $7.5m1.1m shares | Added |
| ALIGN TECHNOLOGY INC ALGN · Put | $2.7m10.0k shares | Unchanged |
| AIR LEASE CORP AL · Put | $585.8k20.0k shares | Unchanged |
| ZOGENIX INC ZGNX · Call | $148.6k5.5k shares | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |